United States · FDA National Drug Code directory
BAVENCIO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44087-3535_990c5dd1-5670-4e2f-af5d-6e87b73b12b5
- Product NDC
- 44087-3535
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- avelumab
- Labeler
- EMD Serono, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20170323
- Source listing expiry
- 20271231
Source-listed ingredients
- AVELUMAB — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (44087-3535-1) / 10 mL in 1 VIAL, SINGLE-DOSE · 44087-3535-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →